Study S002160

Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02198209
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: WITHDRAWN
Enrollment: 0
Start: 2019-12
Primary completion: 2020-07
Lead sponsor: Cedars-Sinai Medical Center
Conditions: Type 2 Diabetes
Interventions: DRUG:Liraglutide
Results posted: FALSE

Registered primary outcomes

Liver glucokinase activity (acute effect) [12 months]
Liver glucokinase activity (chronic effect) [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.